乳がん薬の世界市場展望2017-20276...市場調査レポートについてご紹介

【英文タイトル】Breast Cancer Drug - Global Market Outlook (2017-2026)

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Breast Cancer Drug Market, By Type
5.1 Introduction
5.2 Mitotic Inhibitor
5.3 Aromatase Inhibitor
5.4 Hormonal rec
5.5 HER2 Inhibitor
5.6 Anti-Metabolites
5.7 CDK 4/6 Inhibitor
6 Global Breast Cancer Drug Market, By Drug
6.1 Introduction
6.2 Targeted Therapy Drugs
6.2.1 Ado-Trastuzumab Emtansine
6.2.2 Neratinib
6.2.3 Monoclonal Antibodies (mAbs)
6.2.3.1 Bevacizumab
6.2.3.2 Trastuzumab
6.2.3.3 Other Monoclonal Antibodies (mAbs)
6.2.4 Lapatinib
6.2.5 Tyrosine kinase inhibitors
6.3 Chemotherapy Drugs
6.3.1 Antimetabolites
6.3.1.1 Capecitabine
6.3.1.2 Gemcitabine
6.3.1.3 Fluorouracil
6.3.2 Anthracyclines
6.3.2.1 Epirubicin
6.3.2.2 Doxorubicin
6.3.3 Alkylating Agents
6.3.4 Neoadjuvant Chemotherapy
6.3.5 Adjuvant Chemotherapy
6.3.6 Taxanes
6.3.6.1 Docetaxel
6.3.6.2 Paclitaxel
6.3.7 Advanced Breast Cancer
6.3.8 Epothilones
6.4 Hormone Therapy Drugs
6.4.1 Ecstasy and Related Drug (ERD)
6.4.2 Selective Estrogen-Receptor Modulators (SERMs)
6.4.2.1 Tamoxifen
6.4.2.2 Toremifene
6.4.2.3 Raloxifene
6.4.3 Aromatase Inhibitors
6.4.3.1 Anastrozole
6.4.3.2 Letrozole
6.4.3.3 Megestrol
6.4.5 Luteinising Hormone-Releasing Hormone
6.4.6 Other Hormonal Therapies
6.4.6.1 Goserelin Acetate
6.4.6.2 Fulvestrant
6.4.6.3 Fluoxymesterone
6.5 Other Drugs
7 Global Breast Cancer Drug Market, By Distribution Channel
7.1 Introduction
7.2 Clinics
7.3 Online Pharmacies
7.4 Ambulatory Surgical Centers
7.5 Hospitals
7.6 Retail Pharmacies
8 Global Breast Cancer Drug Market, By Drug
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Argentina
8.4.2 Brazil
8.4.3 Venezuela
8.4.4 Chile
8.4.5 Peru
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Iran
8.5.5 South Africa
8.5.6 Rest of MEA
9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiles
10.1 Novartis AG
10.2 Celgene Corporation
10.3 Janssen Global Services LLC
10.4 Onyx Pharmaceuticals Inc.
10.5 AbbVie, Inc.
10.6 Eli Lilly and Company
10.7 Celldex Therapeutics
10.8 BioNumerik Pharmaceuticals, Inc.
10.9 AstraZeneca
10.10 Merck & Co., Inc.
10.11 Genzyme Corporation
10.12 MacroGenics, Inc.
10.13 F. Hoffmann-La Roche Ltd.
10.14 Biocon
List of Tables
Table 1 Global Breast Cancer Drug Market Outlook, By Region (2016-2026)(US $MN)
Table 2 Global Breast Cancer Drug Market Outlook, By Type (2016-2026)(US $MN)
Table 3 Global Breast Cancer Drug Market Outlook, By Mitotic Inhibitor (2016-2026)(US $MN)
Table 4 Global Breast Cancer Drug Market Outlook, By Aromatase Inhibitor (2016-2026)(US $MN)
Table 5 Global Breast Cancer Drug Market Outlook, By Hormonal rec (2016-2026)(US $MN)
Table 6 Global Breast Cancer Drug Market Outlook, By HER2 Inhibitor (2016-2026)(US $MN)
Table 7 Global Breast Cancer Drug Market Outlook, By Anti-Metabolites (2016-2026)(US $MN)
Table 8 Global Breast Cancer Drug Market Outlook, By CDK 4/6 Inhibitor (2016-2026)(US $MN)
Table 9 Global Breast Cancer Drug Market Outlook, By Drug (2016-2026)(US $MN)
Table 10 Global Breast Cancer Drug Market Outlook, By Targeted Therapy Drugs (2016-2026)(US $MN)
Table 11 Global Breast Cancer Drug Market Outlook, By Ado-Trastuzumab Emtansine (2016-2026)(US $MN)
Table 12 Global Breast Cancer Drug Market Outlook, By Neratinib (2016-2026)(US $MN)
Table 13 Global Breast Cancer Drug Market Outlook, By Monoclonal Antibodies (mAbs) (2016-2026)(US $MN)
Table 14 Global Breast Cancer Drug Market Outlook, By Lapatinib (2016-2026)(US $MN)
Table 15 Global Breast Cancer Drug Market Outlook, By Tyrosine kinase inhibitors (2016-2026)(US $MN)
Table 16 Global Breast Cancer Drug Market Outlook, By Chemotherapy Drugs (2016-2026)(US $MN)
Table 17 Global Breast Cancer Drug Market Outlook, By Antimetabolites (2016-2026)(US $MN)
Table 18 Global Breast Cancer Drug Market Outlook, By Anthracyclines (2016-2026)(US $MN)
Table 19 Global Breast Cancer Drug Market Outlook, By Alkylating Agents (2016-2026)(US $MN)
Table 20 Global Breast Cancer Drug Market Outlook, By Neoadjuvant Chemotherapy (2016-2026)(US $MN)
Table 21 Global Breast Cancer Drug Market Outlook, By Adjuvant Chemotherapy (2016-2026)(US $MN)
Table 22 Global Breast Cancer Drug Market Outlook, By Taxanes (2016-2026)(US $MN)
Table 23 Global Breast Cancer Drug Market Outlook, By Advanced Breast Cancer (2016-2026)(US $MN)
Table 24 Global Breast Cancer Drug Market Outlook, By Epothilones (2016-2026)(US $MN)
Table 25 Global Breast Cancer Drug Market Outlook, By Hormone Therapy Drugs (2016-2026)(US $MN)
Table 26 Global Breast Cancer Drug Market Outlook, By Ecstasy and Related Drug (ERD) (2016-2026)(US $MN)
Table 27 Global Breast Cancer Drug Market Outlook, By Selective Estrogen-Receptor Modulators (SERMs) (2016-2026)(US $MN)
Table 28 Global Breast Cancer Drug Market Outlook, By Aromatase Inhibitors (2016-2026)(US $MN)
Table 29 Global Breast Cancer Drug Market Outlook, By Luteinising Hormone-Releasing Hormone (2016-2026)(US $MN)
Table 30 Global Breast Cancer Drug Market Outlook, By Other Hormonal Therapies (2016-2026)(US $MN)
Table 31 Global Breast Cancer Drug Market Outlook, By Distribution Channel (2016-2026)(US $MN)
Table 32 Global Breast Cancer Drug Market Outlook, By Clinics (2016-2026)(US $MN)
Table 33 Global Breast Cancer Drug Market Outlook, By Online Pharmacies (2016-2026)(US $MN)
Table 34 Global Breast Cancer Drug Market Outlook, By Ambulatory Surgical Centers (2016-2026)(US $MN)
Table 35 Global Breast Cancer Drug Market Outlook, By Hospitals (2016-2026)(US $MN)
Table 36 Global Breast Cancer Drug Market Outlook, By Retail Pharmacies (2016-2026)(US $MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.


【レポート販売概要】

■ タイトル:乳がん薬の世界市場展望2017-20276
■ 英文:Breast Cancer Drug - Global Market Outlook (2017-2026)
■ 発行日:2019年7月
■ 調査会社:Stratistics MRC
■ 商品コード:SMRC20FB349
■ 調査対象地域:グローバル
  • Gastar Exploration Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013
    Gastar Exploration Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Gastar Exploration Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
  • 耐水性接着剤およびシーラントの世界市場:シリコーン、ポリウレタン、アクリル樹脂、エポキシ樹脂、ポリスルフィド
    The market size of waterproof adhesives and sealants, in terms of value, is projected to reach USD 24.75 Billion by 2020, registering a CAGR of 5.95% between 2015 and 2020. High demand in application areas such as building & construction, transportation, electronics & electrical, packaging, labeling, and automotive among others, technological advancements, and continuous new product launches and a …
  • ディーゼル排気液(DEF)の世界市場2018-2022
    About Diesel Exhaust Fluid DEF is a blended aqueous solution composed of 32.5% high-purity urea and 67.5% de-ionized water. DEF is used in the reduction of NOx emissions from diesel engines and is added to selective catalytic reduction systems in which harmful exhaust gas emissions are treated. Technavio’s analysts forecast the global diesel exhaust fluid market to grow at a CAGR of 12.85% during …
  • 指向性エネルギー兵器(DEW)の世界市場予測(~2021年)
    The directed energy weapons market is projected to grow from USD 6.87 Billion in 2016 to USD 24.45 Billion by 2021, at a CAGR of 28.90% during the forecast period. In recent years, the range of advanced offensive and defensive capabilities offered by smart weapons has made them an indispensable component of any military force. This has created an increased demand for directed energy weapons from v …
  • 半導体レーザーの世界市場2016-2020
    About Semiconductor Lasers Semiconductor lasers use semiconductor gain medium, where optical gain is achieved by injecting current at an interband transition with high carrier density in the conduction band. They are compact in size and have low maintenance cost. The material often used in the semiconductor laser is gallium arsenide, and thus it is also known as a gallium arsenide laser. Semicondu …
  • ハイ・パフォーマンス・トラックの世界市場2015-2019
    The high performance truck market is growing at a slow pace mainly due to flat market in matured markets like EMEA and the Americas due to stagnant economic growth leading to low investment in construction and mining activities. Technavios market research analysts estimate the market to reach over 4 million in unit sales during the forecast period. Strict emission norms is forcing the OEMs to adop …
  • 工業用テープの世界市場2016-2020
    About Industrial Tapes Industrial tapes stick to substances when pressure is applied, without any need for solvent, heat, or any other activator. Many variants of these tapes are available in the market, such as single-sided, double-sided, adhesive transfer or transfer adhesive, single-coated, double-coated, carton sealing, masking, electrical and electronics, and others. Adhesive tapes are used f …
  • 世界の無人航空機ペイロード(UAV Payload)市場動向2013-2023:競合環境及び戦略的インサイト
    The report provides a detailed analysis of the competitive landscape of the UAV Payload market. It provides an overview of key UAV Payload companies catering to the UAV Payload sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis. The global UAV payloads industry is highly competitive. The US and various European countries are among the leading …
  • トップ10布ファブリックの世界市場予測(~2021):抗菌繊維品、被覆布、耐火、不織布/繊維品、高機能布、ポリマ被覆布、保護布、テフロン布、スマートテキスタイル、工業用繊維品
    Top 10 fabrics are materials which are produced by weaving, kitting or bonding textile fibers. These are used for various applications ranging from transportation, protective clothing, industrial, furniture & seating, roofing, awnings & canopies, among others. Increasing end-use applications, growing population, improving economic conditions such as rising GDPs & disposable incomes and booming man …
  • 産業用安全の世界市場予測(~2024年)
    “Industrial safety market to exhibit significant growth during 2019–2024”The industrial safety market is estimated to grow from USD 3.3 billion in 2019 to USD 5.4 billion by 2024, at a CAGR of 8.6% during the forecast period. The key factors driving the market’s growth include mandates for safety regulations, rising demand for safety systems in the oil & gas industry, rising need for reliable safe …
  • 浮揚式発電所動向
    Floating Power Plants - Drivers, Deterrents and Developments Summary A power barge or Floating Power Plant (FPP) is an electricity generating facility designed on a floating platform. FPPs have short construction cycles and flexibility for mobility which can provide a quick solution to power shortages. FPPs lack self-propulsion mechanisms, meaning that they must be pulled to the desired location. …
  • 心疾患マーカー検査の世界市場予測:トロポニンI&T、CK-MB、ミオグロビン、BNP、hsCRP
    The cardiac marker testing market is expected to reach ~USD 3.50 Billion by 2021 from USD 2.30 Billion in 2016, at a CAGR of 8.8% between 2016 and 2021. Factors such as growing incidences of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for identification of nov …
  • Ramucirumab (Non-Small Cell Lung Cancer):市場予測と分析(~2022)
    Ramucirumab (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment …
  • 教育機関向けERPソリューションの世界市場
    The education ERP market continues to evolve and exhibits expansive growth in the years to come. ERP in education is not a new concept; ERPs were in full-fledged use in major corporations to ease the management process. The development of technology and widespread demand of computing concepts is currently driving the market for ERP in the education industry. This market is expected to grow substan …
  • 血漿療法の世界市場:ピュアPRP(多血小板血漿)、白血球リッチPRP、ピュア多血小板フィブリン、白血球リッチフィブリン
    The global plasma therapy market comprises various types of platelet-rich plasma that are used by hospitals & clinics and several research institutions. Rise in the number of orthopedic disorders associated with trauma and aging led to the increased demand for minimally-invasive therapies. This has further contributed to the increased demand for PRP in orthopedic, dermatology, nerve injury, cardia …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。